New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report

Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare clinical presentation. To our best knowledge, only three reports have summarized the characteristic manifestations of buprenorphine withdrawa...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacology bulletin Vol. 52; no. 3; pp. 72 - 80
Main Authors: Lin, Yezhe, Zhang, Alexander D, Sun, Ching-Fang, White, Justin B, Qi, Ansi, Farrell, Jessica A, Trestman, Robert L, Martin, Rachel K, Kablinger, Anita S
Format: Journal Article
Language:English
Published: United States MedWorks Media Global 27-06-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare clinical presentation. To our best knowledge, only three reports have summarized the characteristic manifestations of buprenorphine withdrawal psychosis, yet all of them were male. In this case report, we present a 41-year-old female patient with bipolar disorder and comorbid substance use disorder who developed new-onset psychosis and relapse of manic symptoms following abrupt discontinuation of Suboxone. Manic and psychotic symptoms remitted after a short-term hospitalization with the treatment of an antipsychotic and a mood stabilizer. In addition to discussing this case presentation and treatment approach, we review existing literature and discuss possible underlying mechanisms to enhance understanding of this clinical phenomenon.
AbstractList Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare clinical presentation. To our best knowledge, only three reports have summarized the characteristic manifestations of buprenorphine withdrawal psychosis, yet all of them were male. In this case report, we present a 41-year-old female patient with bipolar disorder and comorbid substance use disorder who developed new-onset psychosis and relapse of manic symptoms following abrupt discontinuation of Suboxone. Manic and psychotic symptoms remitted after a short-term hospitalization with the treatment of an antipsychotic and a mood stabilizer. In addition to discussing this case presentation and treatment approach, we review existing literature and discuss possible underlying mechanisms to enhance understanding of this clinical phenomenon.
Author Zhang, Alexander D
White, Justin B
Farrell, Jessica A
Lin, Yezhe
Kablinger, Anita S
Qi, Ansi
Trestman, Robert L
Sun, Ching-Fang
Martin, Rachel K
Author_xml – sequence: 1
  givenname: Yezhe
  surname: Lin
  fullname: Lin, Yezhe
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 2
  givenname: Alexander D
  surname: Zhang
  fullname: Zhang, Alexander D
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 3
  givenname: Ching-Fang
  surname: Sun
  fullname: Sun, Ching-Fang
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 4
  givenname: Justin B
  surname: White
  fullname: White, Justin B
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 5
  givenname: Ansi
  surname: Qi
  fullname: Qi, Ansi
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 6
  givenname: Jessica A
  surname: Farrell
  fullname: Farrell, Jessica A
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 7
  givenname: Robert L
  surname: Trestman
  fullname: Trestman, Robert L
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 8
  givenname: Rachel K
  surname: Martin
  fullname: Martin, Rachel K
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
– sequence: 9
  givenname: Anita S
  surname: Kablinger
  fullname: Kablinger, Anita S
  organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35815178$$D View this record in MEDLINE/PubMed
BookMark eNpVkGtLwzAUhoNM3EX_guQPFJtrUz8I23QqjG14-VzSLl0jbRLS1Lkf4X-24gX9dOA9PM85vGMwMNaoIzDCNMERplQMwCiOqYhYwukQjNv2JY4RTTk7AUPCBGIoESPwvlL7aG1aFeCmPRSVDbqAj4fGBdu0cGHr2u612cFp7jsX4KxzXhnrXaWNuljJ2r71Z-G1bgtrgjadDNoaqA2UcKEaWSu46SNlAtzrUMGZdraW_hOwfqv8JZzCuWwVfFDO-nAKjktZt-rse07A8-LmaX4XLde39_PpMnJIoBAVlCtZppgnBBGeCpLIkuItJqKkjCQlKQtW5DIvUpowQjDCecoE51JikcdSkAm4-vK6Lm_Utuj_87LOnNeN9IfMSp393xhdZTv7mqWYMIJ4Lzj_K_glf4olH9a2eyI
ContentType Journal Article
Copyright Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. 2022
Copyright_xml – notice: Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
– notice: Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. 2022
DBID CGR
CUY
CVF
ECM
EIF
NPM
5PM
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2472-2448
EndPage 80
ExternalDocumentID 35815178
Genre Review
Case Reports
GroupedDBID ---
-~X
5RE
ABOCM
ABPPZ
ACNCT
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
E3Z
EBS
ECM
EIF
EJD
EMOBN
F5P
MK0
NPM
OK1
RPM
SJN
SV3
TWZ
WH7
5PM
ID FETCH-LOGICAL-p181t-c46eaf926731369837af42d238f4537f3fc5cbabc947533212b95866aa28b0a83
IEDL.DBID RPM
ISSN 0048-5764
IngestDate Tue Sep 17 21:30:14 EDT 2024
Sat Sep 28 08:14:08 EDT 2024
IsPeerReviewed false
IsScholarly false
Issue 3
Keywords buprenorphine
two-hit hypothesis
psychosis
substance-withdrawal
mania
Language English
License Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p181t-c46eaf926731369837af42d238f4537f3fc5cbabc947533212b95866aa28b0a83
PMID 35815178
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9235316
pubmed_primary_35815178
PublicationCentury 2000
PublicationDate 20220627
PublicationDateYYYYMMDD 2022-06-27
PublicationDate_xml – month: 6
  year: 2022
  text: 20220627
  day: 27
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Psychopharmacology bulletin
PublicationTitleAlternate Psychopharmacol Bull
PublicationYear 2022
Publisher MedWorks Media Global
Publisher_xml – name: MedWorks Media Global
SSID ssj0014965
Score 1.8491858
SecondaryResourceType review_article
Snippet Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare...
SourceID pubmedcentral
pubmed
SourceType Open Access Repository
Index Database
StartPage 72
SubjectTerms Adult
Antipsychotic Agents - therapeutic use
Bipolar Disorder - drug therapy
Buprenorphine - adverse effects
Buprenorphine, Naloxone Drug Combination - therapeutic use
Complicated Case History
Female
Humans
Male
Naloxone - adverse effects
Psychotic Disorders - drug therapy
Substance Withdrawal Syndrome - drug therapy
Substance Withdrawal Syndrome - etiology
Title New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report
URI https://www.ncbi.nlm.nih.gov/pubmed/35815178
https://pubmed.ncbi.nlm.nih.gov/PMC9235316
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3JTsMwEIYt2hMXxL6jOaCeappmdbh1FRdKpYLErbKdREQii5pU0IfgnRnHTUuvnOMokcfy_08y_oaQe4FZT-BzSb2IBdSWjFOfhT5lJsq5wwInYlUT25k3eWfDkcLkOPVZmKpoX4r4If1MHtL4o6qtzBPZqevEOtPnAZoSXDpup0Ea6A3rFH3960AB0PVvZUbRTKvGO4rx5XRVJ7WNyuxWQP6RlPEhOVh7QejpZx6RvTA9Jq2phkmv2vC6PRtVtKEF0y1menVCfnB_oi9pEZagdzEcBrNVkpdZUsAY45t9oS5BTyyWeQn9paJXZjitiowx4Z_Zd5aGMIwLVa0epxr5DXEKHMZhgroBU81cBfWtFvpxrrJgqHGdj9CDAUogaAt_St7Go9fBE103V6A5inpJpe2GPPJN17O6lutjnsoj2wxQwSPbsbzIiqQjBRfStzGjsVDhhO8w1-XcZMLgzDojzRTf84JAwNH1SM49YXLb6XJ0AIYRhNI1hOLdRZfkXM_2PNcEjXkdkEvi7cRhM0BBr3ev4Fqo4Nfr2F_9-85rsm-qIwyGS03vhjTLxTK8JY0iWN5VC-kXdmjU3A
link.rule.ids 230,315,729,782,786,887,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3JTsMwEIYtKAe4sO_bHBAnTNOsDre2UIGAUokicatsJxGRmkUkFfQheGfGcQP0yjmOZGkc___E428IOROY9QQ-l9SLWEBtyTj1WehTZqKcOyxwIlY1sX32-q_s-kZhcpz6LkxVtC9FfJmOk8s0fqtqK_NENus6sebgsYumBJeO21wkS_i9GkadpM8ODxQCXR8sM4p2WrXeUZQvp6V6qf3ozHwN5B9R6a39czrrZHXmIqGtH2-QhTDdJOcDjaGeXsDw91ZVcQHnMPgFVE-3yBfubPQpLcIS9P6Hw-B5muRllhTQw5WRfaCiQVu8T_ISOhPFvcwwIIqp0efj7DNLQ7iOC1XnHqcaFg5xChx6YYKKAwNNawX1lxc6ca7yZ6hBn1fQhi6KJ2jzv01eejfD7i2dtWWgOdqBkkrbDXnkm65ntSzXxwyXR7YZoPZHtmN5kRVJRwoupG9jLmShNgrfYa7LucmEwZm1QxopznOPQMDRL0nOPWFy22lx9A6GEYTSNYQi5UX7ZFdHaZRr9saoDuQ-8ebi9zNA4bLnn2DYKmz2LEwH_37zlCzfDh8fRg93_ftDsmKqixCGS03viDTK90l4TBaLYHJSLcZvl0PqYQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LT9wwEMetspUQl5byaCmvOSBOmM3m6XDbB1ERsEQCpN5WthOrkTYPkaza_RD9zh3Huwt7Lec4kqVx_P9PPP4NIWcCs54k5JIGiiXUlYzTkKUhZTbKuccST7G2ie1jMP7JRtcak7Nq9dUW7UuRXRbT_LLIfrW1lVUuu8s6sW58P0RTgkvH71aJ6m6Qj_jNWvYyUV8cIGgMujlcZhQttW6_o0lfXk_3U1tpzXod5BthiT6_Y0rb5NPCTULfDPlCPqTFDjmPDY56fgFPr7er6gs4h_gVVD3fJX9xh6MPRZ02YPZBHAaP87xqyryGCFdI-RuVDfriZVY1MJhp_mWJgdFsjTGfln_KIoVRVut696ww0HDICuAQpTkqD8SG2gr6by8Mskrn0bAEfl5BH4YoomCSgD3yHF0_DX_QRXsGWqEtaKh0_ZSr0PYDp-f4IWa6XLl2gh5AuZ4TKEdJTwouZOhiTuSgRorQY77Puc2ExZmzTzoFzvMbgYSjb5KcB8Lmrtfj6CEsK0mlbwlNzFMH5KuJ1KQyDI7JMpgHJFiL4WqAxmavP8HQtfjsRai-__ebp2QzHkWTu5vx7SHZsvV9CMundnBEOs3LLD0mG3UyO2nX4z_e-uzh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New-Onset+Psychotic+Symptoms+Following+Abrupt+Buprenorphine%2FNaloxone+Discontinuation+in+a+Female+Patient+with+Bipolar+Disorder%3A+A+Case+Report&rft.jtitle=Psychopharmacology+bulletin&rft.au=Lin%2C+Yezhe&rft.au=Zhang%2C+Alexander+D&rft.au=Sun%2C+Ching-Fang&rft.au=White%2C+Justin+B&rft.date=2022-06-27&rft.pub=MedWorks+Media+Global&rft.issn=0048-5764&rft.eissn=2472-2448&rft.volume=52&rft.issue=3&rft.spage=72&rft.epage=80&rft_id=info%3Apmid%2F35815178&rft.externalDBID=PMC9235316
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0048-5764&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0048-5764&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0048-5764&client=summon